350543 <common-name>N-[(e)-(3,4-dimethoxyphenyl)methylideneamino]-2-[4-[(e)-[3-[(2-ethylanilino)methyl]-4-oxo-2-sulfanylidene-1,3-thiazolidin-5-ylidene]methyl]phenoxy]acetamide</common-name> <description>N-[(e)-(3,4-dimethoxyphenyl)methylideneamino]-2-[4-[(e)-[3-[(2-ethylanilino)methyl]-4-oxo-2-sulfanylidene-1,3-thiazolidin-5-ylidene]methyl]phenoxy]acetamide is a chemical compound with the formula C30H30N4O5S2. With an average molecular weight of 590.70 g/mol, N-[(e)-(3,4-dimethoxyphenyl)methylideneamino]-2-[4-[(e)-[3-[(2-ethylanilino)methyl]-4-oxo-2-sulfanylidene-1,3-thiazolidin-5-ylidene]methyl]phenoxy]acetamide is a heavy molecule.</description> <cas>139207-45-7</cas> <pubchem-id>9588720</pubchem-id> <chemical-formula>C30H30N4O5S2</chemical-formula> <weight>590.7</weight> <appearance nil="true"/> <melting-point nil="true"/> <boiling-point nil="true"/> <density nil="true"/> <solubility nil="true"/> <specific-gravity nil="true"/> <flash-point nil="true"/> <vapour-pressure nil="true"/> <route-of-exposure nil="true"/> <target nil="true"/> <mechanism-of-toxicity nil="true"/> <metabolism nil="true"/> <toxicity nil="true"/> <lethaldose nil="true"/> <carcinogenicity nil="true"/> <use-source nil="true"/> <min-risk-level nil="true"/> <health-effects nil="true"/> <symptoms nil="true"/> <treatment nil="true"/> <created-at type="dateTime">2026-08-31T15:40:35Z</created-at> <updated-at type="dateTime">2026-08-31T15:40:35Z</updated-at> <interacting-proteins nil="true"/> <wikipedia nil="true"/> <uniprot-id nil="true"/> <kegg-compound-id nil="true"/> <omim-id nil="true"/> <chebi-id nil="true"/> <biocyc-id nil="true"/> <ctd-id nil="true"/> <stitch-id nil="true"/> <drugbank-id nil="true"/> <pdb-id nil="true"/> <actor-id nil="true"/> <organism nil="true"/> <export type="boolean">true</export> <metabolizing-proteins nil="true"/> <transporting-proteins nil="true"/> <moldb-smiles>CCC1=CC=CC=C1NCN2C(=O)C(=CC3=CC=C(C=C3)OCC(=O)NN=CC4=CC(=C(C=C4)OC)OC)SC2=S</moldb-smiles> <moldb-formula>C30H30N4O5S2</moldb-formula> <moldb-inchi>InChI=1S/C30H30N4O5S2/c1-4-22-7-5-6-8-24(22)31-19-34-29(36)27(41-30(34)40)16-20-9-12-23(13-10-20)39-18-28(35)33-32-17-21-11-14-25(37-2)26(15-21)38-3/h5-17,31H,4,18-19H2,1-3H3,(H,33,35)/b27-16+,32-17+</moldb-inchi> <moldb-inchikey>PMGWXBNAPUSTNX-UTPQEOGGSA-N</moldb-inchikey> <moldb-average-mass type="decimal" nil="true"/> <moldb-mono-mass type="decimal">590.1657624</moldb-mono-mass> <origin nil="true"/> <state nil="true"/> <logp>6.4</logp> <hmdb-id nil="true"/> <chembl-id nil="true"/> <chemspider-id nil="true"/> <structure-image-file-name nil="true"/> <structure-image-content-type nil="true"/> <structure-image-file-size type="integer" nil="true"/> <structure-image-updated-at type="dateTime" nil="true"/> <biodb-id nil="true"/> <synthesis-reference nil="true"/> <structure-image-caption nil="true"/> <chemdb-id>CHEM346436</chemdb-id> <dsstox-id nil="true"/> <toxcast-id nil="true"/> <stoff-ident-origin nil="true"/> <stoff-ident-id nil="true"/> <susdat-id nil="true"/> <iupac>N-[(e)-(3,4-dimethoxyphenyl)methylideneamino]-2-[4-[(e)-[3-[(2-ethylanilino)methyl]-4-oxo-2-sulfanylidene-1,3-thiazolidin-5-ylidene]methyl]phenoxy]acetamide</iupac> <moldb-polar-surface-area nil="true"/> <moldb-refractivity nil="true"/> <moldb-polarizability nil="true"/> <moldb-rotatable-bond-count nil="true"/> <moldb-acceptor-count nil="true"/> <moldb-donor-count nil="true"/> <moldb-pka-strongest-acidic nil="true"/> <moldb-pka-strongest-basic nil="true"/> <moldb-physiological-charge nil="true"/> <moldb-number-of-rings nil="true"/> <moldb-alogps-logp nil="true"/> <moldb-alogps-logs nil="true"/> <moldb-alogps-solubility nil="true"/> <kingdom>Organic compounds</kingdom> <superklass>Benzenoids</superklass> <klass>Benzene and substituted derivatives</klass> <subklass>Methoxybenzenes</subklass> <paper-count type="integer" nil="true"/> <sync-id>CED0300848</sync-id> <structure-inchikey>PMGWXBNAPUSTNX-UHFFFAOYSA-N</structure-inchikey> <structure-fingerprint>400040000000008002420000000008000000000000800001000000004000004040820004222000000000000000000000000000000000000000000000000000000000000000000800000000000000200000100003000002040000080000000000000100000000400001801100000000000801001000000000000000000010000000400000008000000000000080900000000001000000c0000400000000000000000000000014000000080000000080000020080000000000000400000080000000000000040000000000400000000000008000040000000200000400000100000008000000001048010000800400000000000020000000080000004008</structure-fingerprint> <structure-pattern-fingerprint>5014c010cd32864081805b608138ba00180014008105206000bda0408224c84c6c021050139000000100412800c00000046102a5c28d322d0164f43908a04098c7510c111a901600009010c0027202010806a58051a11f3340040462440249040c3805af00488220600c1484ddb4004d208680500901e90479b804600271000210c048184ef082080c86825c483c0008391d181244409e8a500008206040468640d310131090c0308a042960257c35104ac100028941084018844e304cc00212a010c8a4a4d8013301c18484541342980c010011031850200d6002040800230490104d100a81014413080403599220820050043080c2040e1108908052010606</structure-pattern-fingerprint> <structure-pickle type="binary" encoding="base64">776t3gAAAAAQAAAAAwAAAAAAAAApAAAALAAAAIABBgBgAAAAAQMGAGAAAAAC AgZAKAAAAAMEBkBoAAAAAwMBBkBoAAAAAwMBBkBoAAAAAwMBBkBoAAAAAwMB BkAoAAAAAwQHAGgAAAADAgEGAGAAAAACAgcAKAAAAAMDBgAoAAAAAwQIACgA AAADAgYAKAAAAAMEBgBoAAAAAwMBBkAoAAAAAwQGQGgAAAADAwEGQGgAAAAD AwEGQCgAAAADBAZAaAAAAAMDAQZAaAAAAAMDAQgAKAAAAAMCBgBgAAAAAgIG ACgAAAADBAgAKAAAAAMCBwBoAAAAAwIBBwAoAAAAAwMGAGgAAAADAwEGQCgA AAADBAZAaAAAAAMDAQZAKAAAAAMEBkAoAAAAAwQGQGgAAAADAwEGQGgAAAAD AwEIACgAAAADAgYAYAAAAAEDCAAoAAAAAwIGAGAAAAABAxAAIAAAAAIGACgA AAADBBAAKAAAAAMCCwABAAECAAIDaAwDBGgMBAVoDAUGaAwGB2gMBwggCAkA CQoACgsgCwwoAgsNIA0OKAIODyAPEGgMEBFoDBESaAwSE2gMExRoDBIVIBUW ABYXABcYKAIXGSAZGiAaGygCGxwgHB1oDB0eaAweH2gMHyBoDCAhaAwfIiAi IwAeJCAkJQANJgAmJwAnKCgCBwJoDCcKIBQPaAwhHGgMQgQAAAAGAgcGBQQD BQsKJyYNBhAREhMUDwYdHh8gIRwXBAAAAAAAAAAW </structure-pickle> <structure-indexed-at type="dateTime">2026-09-19T05:48:32Z</structure-indexed-at> </compound>